創薬におけるクロマトグラフィー樹脂の世界市場:イオン交換クロマトグラフィー、親和クロマトグラフィー、疎水性相互作用クロマトグラフィー等

◆英語タイトル:Chromatography Resins Market in Drug Discovery by Technique (Ion Exchange, Affinity (Protein A, G & L), Hydrophobic Interaction, Size Exclusion, Multi Modal and Others) & Geography - Global Market Trends & Forecasts to 2020
◆商品コード:MAM-CH-3328
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2015年4月17日
◆ページ数:138
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:化学
◆販売価格オプション(消費税別)
Single UserUSD4,650 ⇒換算¥511,500見積依頼/購入/質問フォーム
Multi User (Five User)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD7,150 ⇒換算¥786,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、創薬におけるクロマトグラフィー樹脂の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、産業動向、バリューチェーン分析、市場シェア分析、市場環境分析、技術別分析、地域別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The market for chromatography resins in drug discovery application is estimated at $238.07 Million in 2014 and is projected to grow at a CAGR of 7.0% between 2015 and 2020. The chromatography resins for drug discovery can be made of natural polymers, synthetic polymers or inorganic materials with ligands attached to them. This report on chromatography resins market in drug discovery covers all major regions such as Asia-Pacific, North America, Europe, and Rest of the World. The report analyzes market trends and forecasts from 2013 to 2020. Market estimations have been provided in terms of consumption volume (liters) and market revenue (USD). The global as well as regional markets have been segmented by technique such as ion exchange, affinity, hydrophobic interaction, size exclusion, multi-modal and others.

The report analyzes the market dynamics such as drivers, restraints, and opportunities, and winning imperatives. Major companies such as General Electric Company, Bio-Rad Laboratories, Thermo Fisher, Tosoh Corporation, and Pall Corporation have been profiled in this report. The report also provide the analysis of competitive landscape based on the recent developments in the market.

For this report, various secondary sources such as chemical magazines, encyclopedia, directories, technical handbooks, company annual reports, industry association publications, articles, trade websites, and databases have been referred to identify and collect information useful for this extensive commercial study of global chromatography resins market in drug discovery. The primary sources – experts from related industries and suppliers – have been interviewed to obtain and verify critical information as well as to assess the future prospects and market estimations.

The chromatography resins market in drug discovery is highly consolidatesd with presence of a few global manufacturers who capture a large share of the market. These manufacturers are focused on providing advanced products to their customers and in the recent past have launched a number of new products.

Chromatography resins for drug discovery can be classified into six categories based on the technique they are used in. Affinity chromatography is the largest segment, in terms of value. It accounts for around half the total market size, primarily due to its high cost. The Proetin A chromatography is the largest sub-type. The increase in critical diseases has led to high demand for therapeutic monoclonal antibodies, driving along with it the demand for Protein A affinity chromatography.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 14
1.3.1.1 By technique 14
1.3.1.2 By region 14
1.3.2 YEARS CONSIDERED 14
1.4 CURRENCY & PRICING 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 15

2 RESEARCH METHODOLOGY 16
2.1 MARKET SIZE ESTIMATION 17
2.2 MARKET BREAKDOWN & DATA TRIANGULATION 20
2.3 MARKET SHARE ESTIMATION 21
2.3.1 KEY INSIGHTS 22
2.3.2 ASSUMPTIONS 23

3 EXECUTIVE SUMMARY 24

4 PREMIUM INSIGHTS 27
4.1 ATTRACTIVE OPPORTUNITIES IN THE CHROMATOGRAPHY RESINS MARKET 27
4.2 CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY: REGIONAL SEGMENTS 28
4.3 AFFINITY RESINS MARKET IN NORTH AMERICA 29
4.4 CHROMATOGRAPHY RESINS MARKET ATTRACTIVENESS 30
4.5 CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE (2014) 31
4.6 CHROMATOGRAPHY RESINS MARKET: DEVELOPING VS. DEVELOPED NATIONS 31
4.7 FASTEST-GROWING MARKETS, BY TECHNIQUE (2014) 32
4.8 LIFE CYCLE ANALYSIS, BY REGION 33

5 MARKET OVERVIEW 34
5.1 INTRODUCTION 34
5.2 MARKET SEGMENTATION 34
5.3 MARKET DYNAMICS 35
5.3.1 DRIVERS 36
5.3.1.1 Increasing demand for therapeutic antibodies 36
5.3.1.2 Growing biopharmaceutical R&D activities 37
5.3.2 RESTRAINTS 38
5.3.2.1 High-cost of affinity resins 38
5.3.2.2 Lack of adequate skilled professionals 39
5.3.3 OPPORTUNITIES 39
5.3.3.1 High growth of biopharmaceutical R&D activity in Asia-Pacific 39
5.3.3.2 Increasing demand for disposable pre-packed columns 39

6 INDUSTRY TRENDS 41
6.1 INTRODUCTION 41
6.2 VALUE CHAIN ANALYSIS 41
6.3 PORTER’S FIVE FORCES ANALYSIS 42
6.3.1 THREAT OF SUBSTITUTES 42
6.3.2 BARGAINING POWER OF SUPPLIERS 43
6.3.3 BARGAINING POWER OF BUYERS 43
6.3.4 THREAT OF NEW ENTRANTS 43
6.3.5 INTENSITY OF RIVALRY 43
6.4 STRATEGIC BENCHMARKING 44
6.4.1 NEW PRODUCT LAUNCHES 44
6.4.2 RESEARCH & DEVELOPMENT 45

7 CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY, BY TECHNIQUE 46
7.1 INTRODUCTION 47
7.2 MARKET SIZE & PROJECTION 47
7.3 ION EXCHANGE CHROMATOGRAPHY (IEX) RESINS 49
7.4 AFFINITY CHROMATOGRAPHY RESINS 50
7.4.1 PROTEIN A AFFINITY RESINS 52
7.4.2 PROTEIN G/L AFFINITY RESINS 53
7.5 HYDROPHOBIC INTERACTION CHROMATOGRAPHY (HIC) 54
7.6 SIZE EXCLUSION CHROMATOGRAPHY (SEC) RESINS 55
7.7 MULTI-MODAL CHROMATOGRAPHY RESINS 57
7.8 OTHERS 58

8 CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY, REGIONAL ANALYSIS 61
8.1 INTRODUCTION 62
8.2 NORTH AMERICA 63
8.2.1 GROWTH IN NORTH AMERICA IS DRIVEN BY THE DEMAND IN U.S. 65
8.2.2 U.S. 65
8.2.3 CANADA 67
8.2.4 MEXICO 69

8.3 EUROPE 70
8.3.1 U.K. 72
8.3.2 GERMANY 74
8.3.3 FRANCE 75
8.3.4 SPAIN 77
8.3.5 AUSTRIA & SWITZERLAND 78
8.3.6 SCANDINAVIA 80
8.4 ASIA-PACIFIC 81
8.4.1 CHINA 83
8.4.2 JAPAN 85
8.4.3 SOUTH KOREA 86
8.4.4 INDIA 88
8.5 ROW 90
8.5.1 BRAZIL 91
8.5.2 MIDDLE EAST 93
8.5.3 AFRICA 94

9 COMPETITIVE LANDSCAPE 96
9.1 OVERVIEW 96
9.2 NEW PRODUCT LAUNCHES: THE MOST POPULAR GROWTH STRATEGY 97
9.3 MAXIMUM DEVELOPMENTS IN NORTH AMERICA, 2010–2014 99
9.4 MAXIMUM DEVELOPMENTS RECORDED IN 2011 100
9.5 GENERAL ELECTRIC COMPANY: THE MOST ACTIVE PLAYER BETWEEN 2010 & 2014 101
9.6 COMPETITIVE SITUATION & TRENDS 102
9.6.1 NEW PRODUCT LAUNCHES 102
9.6.2 RESEARCH & DEVELOPMENT 103
9.6.3 MERGERS & ACQUISITIONS 104
9.6.4 CONTRACTS & AGREEMENTS 104
9.6.5 EXPANSIONS 105

10 COMPANY PROFILES 106
(Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*
10.1 INTRODUCTION 106
10.2 MERCK KGAA 107
10.3 TOSOH CORPORATION 110
10.4 GENERAL ELECTRIC COMPANY 112
10.5 PALL CORPORATION 115
10.6 BIO-RAD LABORATORIES, INC. 118
10.7 THERMO FISHER SCIENTIFIC INC. 121
10.8 PUROLITE CORPORATION 123
10.9 SEPRAGEN CORPORATION 125
10.10 KNAUER WISSENSCHAFTLICHE GERÄTE GMBH 126
10.11 KANEKA CORPORATION 127
10.12 GENSCRIPT USA INC. 129
*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.

11 APPENDIX 130
11.1 INSIGTHS FROM INDUSTRY EXPERTS 130
11.2 RECENT DEVELOPMENTS 130
11.3 DISCUSSION GUIDE 132
11.4 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 135
11.5 AVAILABLE CUSTOMIZATIONS 135
11.6 RELATED REPORTS 136

LIST OF TABLES

TABLE 1 BIOSIMILARS IN RESEARCH & DEVELOPMENT, 2014 37
TABLE 2 IMPACT ANALYSIS OF DRIVERS 38
TABLE 3 IMPACT ANALYSIS OF RESTRAINTS 39
TABLE 4 IMPACT ANALYSIS OF OPPORTUNITIES 40
TABLE 5 CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS) 48
TABLE 6 CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION) 48
TABLE 7 AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 ($MILLION) 49
TABLE 8 IEX CHROMATOGRAPHY RESIN MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 (LITERS) 50
TABLE 9 ION EXCHANGE CHROMATOGRAPHY RESIN MARKET SIZE IN DRUG DISCOVERY,
BY REGION, 2013-2020 ($MILLION) 50
TABLE 10 AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY REGION, 2013-2020 (LITERS) 51
TABLE 11 AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY REGION, 2013-2020 ($MILLION) 52
TABLE 12 PROTEIN A RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION,
2013-2020 ($MILLION) 52
TABLE 13 PROTEIN G/L RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION,
2013-2020 ($MILLION) 53
TABLE 14 PROTEIN A, G & L: BINDING CAPACITIES FOR DIFFERENT IMMUNOGLOBULIN SPECIES 53
TABLE 15 HIC RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 (LITERS) 55
TABLE 16 HIC RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 ($MILLION) 55
TABLE 17 SEC RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 (LITERS) 56
TABLE 18 SEC RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION,
2013-2020 ($MILLION) 56
TABLE 19 MULTI-MODAL RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION,
2013-2020 (LITERS) 58
TABLE 20 MULTI-MODAL RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION,
2013-2020 ($MILLION) 58
TABLE 21 OTHER RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION,
2013-2020 (LITERS) 59
TABLE 22 OTHER RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION,
2013-2020 ($MILLION) 60
TABLE 23 CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION,
2013–2020 (LITERS) 63
TABLE 24 CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION,
2013–2020 ($MILLION) 63
TABLE 25 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY COUNTRY, 2013–2020 (LITERS) 65
TABLE 26 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY COUNTRY, 2013–2020 ($MILLION) 65
TABLE 27 U.S.: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013–2020 (LITERS) 66
TABLE 28 U.S.: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013–2020 ($MILLION) 66
TABLE 29 U.S.: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TYPE, 2013–2020 ($MILLION) 67
TABLE 30 CANADA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013–2020 (LITERS) 67
TABLE 31 CANADA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013–2020 ($MILLION) 68
TABLE 32 CANADA: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013–2020 ($MILLION) 68
TABLE 33 MEXICO: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013–2020 (LITERS) 69
TABLE 34 MEXICO: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013–2020 ($MILLION) 69
TABLE 35 MEXICO: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013–2020 ($MILLION) 70
TABLE 36 EUROPE: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY COUNTRY, 2013–2020 (LITERS) 71
TABLE 37 EUROPE: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY COUNTRY, 2013–2020 ($MILLION) 72
TABLE 38 U.K.: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013–2020 (LITERS) 72
TABLE 39 U.K.: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013–2020 ($MILLION) 73
TABLE 40 U.K.: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TYPE, 2013–2020 ($MILLION) 73
TABLE 41 GERMANY: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013–2020 (LITERS) 74
TABLE 42 GERMANY: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013–2020 ($MILLION) 74
TABLE 43 GERMANY: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013–2020 ($MILLION) 75
TABLE 44 FRANCE: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013–2020 (LITERS) 75
TABLE 45 FRANCE: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013–2020 ($MILLION) 76
TABLE 46 FRANCE: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013–2020 ($MILLION) 76
TABLE 47 SPAIN: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013–2020 (LITERS) 77
TABLE 48 SPAIN: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013–2020 ($MILLION) 77
TABLE 49 SPAIN: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TYPE, 2013–2020 ($MILLION) 78
TABLE 50 AUSTRIA & SWITZERLAND: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013–2020 (LITERS) 78
TABLE 51 AUSTRIA & SWITZERLAND: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION) 79
TABLE 52 AUSTRIA & SWITZERLAND: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION) 79
TABLE 53 SCANDINAVIA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 (LITERS) 80
TABLE 54 SCANDINAVIA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 ($MILLION) 80
TABLE 55 SCANDINAVIA: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION) 81
TABLE 56 ASIA-PACIFIC: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY COUNTRY, 2013-2020 (LITERS) 83
TABLE 57 ASIA-PACIFIC: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY COUNTRY, 2013-2020 ($MILLION) 83
TABLE 58 CHINA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 (LITERS) 84
TABLE 59 CHINA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 ($MILLION) 84
TABLE 60 CHINA: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TYPE, 2013-2020 ($MILLION) 84
TABLE 61 JAPAN: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 (LITERS) 85
TABLE 62 JAPAN: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 ($MILLION) 85
TABLE 63 JAPAN: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TYPE, 2013-2020 ($MILLION) 86
TABLE 64 SOUTH KOREA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 (LITERS) 87
TABLE 65 SOUTH KOREA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 ($MILLION) 87
TABLE 66 SOUTH KOREA: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION) 88
TABLE 67 INDIA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 (LITERS) 88
TABLE 68 INDIA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 ($MILLION) 89
TABLE 69 INDIA: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TYPE, 2013-2020 ($MILLION) 89
TABLE 70 ROW: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY COUNTRY, 2013-2020 (LITERS) 90
TABLE 71 ROW: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY COUNTRY, 2013-2020 ($MILLION) 91
TABLE 72 BRAZIL: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 (LITERS) 91
TABLE 73 BRAZIL: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 ($MILLION) 92
TABLE 74 BRAZIL: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION) 92
TABLE 75 MIDDLE EAST: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 (LITERS) 93
TABLE 76 MIDDLE EAST: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 ($MILLION) 93
TABLE 77 MIDDLE EAST: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION) 94
TABLE 78 AFRICA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 (LITERS) 94
TABLE 79 AFRICA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY,
BY TECHNIQUE, 2013-2020 ($MILLION) 95
TABLE 80 AFRICA: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION) 95
TABLE 81 NEW PRODUCT LAUNCH, 2010–2014 102
TABLE 82 RESEARCH & DEVELOPMENT, 2010–2014 103
TABLE 83 MERGERS & ACQUISITIONS, 2010–2014 104
TABLE 84 CONTRACTS & AGREEMENTS, 2010–2014 104
TABLE 85 EXPANSIONS, 2010–2014 105
TABLE 86 DEVELOPMENTS, 2010–2014 130


LIST OF FIGURES

FIGURE 1 CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY, RESEARCH DESIGN 16
FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 18
FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 19
FIGURE 4 BREAK DOWN OF PRIMARY INTERVIEWS, BY DESIGNATION & REGION 19
FIGURE 5 CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY: DATA TRIANGULATION 20
FIGURE 6 DATA FROM SECONDARY SOURCES 21
FIGURE 7 DATA FROM PRIMARY SOURCES 22
FIGURE 8 PROTEIN A TO DOMINATE THE MARKET 24
FIGURE 9 AFFINITY CHROMATOGRAPHY MARKET TO REGISTER THE FASTEST GROWTH IN
ASIA-PACIFIC 25
FIGURE 10 CHINA IS THE LARGEST CONSUMER OF PROTEIN A AFFINITY CHROMATOGRAPHY 26
FIGURE 11 CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY TO REGISTER MODERATE GROWTH 27
FIGURE 12 ASIA-PACIFIC TO GROW AT HIGHEST RATE BETWEEN 2015 & 2020 28
FIGURE 13 U.S. CAPTURES THE LION’S SHARE IN THE NORTH AMERICA AFFINITY RESINS MARKET IN 2014 29
FIGURE 14 CHINA, MEXICO & INDIA WILL BE THE FASTEST-GROWING MARKETS DURING THE PROJECTED PERIOD 30
FIGURE 15 AFFINITY RESINS TO BE THE MOST ATTRACTIVE MARKET 31
FIGURE 16 CHINA TO EMERGE AS A LUCRATIVE MARKET 31
FIGURE 17 CHROMATOGRAPHY RESINS IN DRUG DISCOVERY HAS HIGH GROWTH POTENTIAL IN THE EMERGING ECONOMIES 32
FIGURE 18 HIGH GROWTH POTENTIAL IN ASIA-PACIFIC FOR THE CHROMATOGRAPHY RESINS IN DRUG DISCOVERY 33
FIGURE 19 BY TECHNIQUE 34
FIGURE 20 BY REGION 35
FIGURE 21 OVERVIEW OF THE MARKET FORCES GOVERNING CHROMATOGRAPHY RESINS MARKET 35
FIGURE 22 ANNUAL APPROVALS OF MAB & ITS RELATED PRODUCTS IN U.S. & EUROPE,
2003– 2014 36
FIGURE 23 SPENDING ON BIOPHARMACEUTICAL RESEARCH, 2005–2020 ($BILLION) 38
FIGURE 24 VALUE CHAIN ANALYSIS FOR CHROMATOGRAPHY RESINS IN DRUG DISCOVERY 41
FIGURE 25 PORTER’S FIVE FORCES ANALYSIS: ENTRY OF NEW PLAYERS WILL IMPACT THE MARKET 42
FIGURE 26 STRATEGIC BENCHMARKING: KEY PLAYERS LAUNCHED A NUMBER OF NEW PRODUCTS 44
FIGURE 27 STRATEGIC BENCHMARKING: COMPANIES FOCUSED ON INNOVATION 45
FIGURE 28 AFFINITY RESINS TO REGISTER THE HIGHEST CAGR FOR THE PROJECTED PERIOD 47
FIGURE 29 NORTH AMERICA IS THE LARGEST MARKET FOR IEX RESINS 49
FIGURE 30 INCREASING DEMAND FOR ANTIBODY PURIFICATION IN DRUG DISCOVERY TO DRIVE THE AFFINITY RESINS MARKET 51
FIGURE 31 HIC RESINS TO WITNESS DECENT GROWTH DURING THE FORECAST PERIOD 54
FIGURE 32 NORTH AMERICA IS THE LARGEST MARKET FOR SEC RESINS IN DRUG DISCOVERY 56
FIGURE 33 NORTH AMERICA TO DOMINATE THE MARKET 57
FIGURE 34 EARLY-STAGE-PURIFICATION REQUIREMENTS TO DRIVE DEMAND FOR OTHER CHROMATOGRAPHY RESINS 59
FIGURE 35 REGIONAL SNAPSHOT (2015–2020)–RAPID GROWTH MARKETS ARE EMERGING AS NEW STRATEGIC LOCATIONS 62
FIGURE 36 PROTEIN A AFFINITY RESINS IN CHINA TO WITNESS HIGH GROWTH 62
FIGURE 37 NORTH AMERICA MARKET SNAPSHOT: U.S. TO CONTINUE TO DOMINATE THE MARKET 64
FIGURE 38 EUROPE MARKET SNAPSHOT: GERMANY, AUSTRIA & SWITZERLAND EXPECTED TO BE LUCRATIVE MARKETS FOR PROTEIN A RESINS 71
FIGURE 39 ASIA-PACIFIC MARKET SNAPSHOT: CHINA IS THE MOST LUCRATIVE MARKET 82
FIGURE 40 BRAZIL DOMINATES THE ROW CHROMATOGRAPHY RESINS MARKET 90
FIGURE 41 KEY GROWTH STRATEGIES IN CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY, 2010–2014 97
FIGURE 42 COMPANIES PRIMARILY ADOPTED ORGANIC GROWTH STRATEGIES 98
FIGURE 43 NEW PRODUCT LAUNCHES MADE NORTH AMERICA THE MOST ACTIVE REGION 99
FIGURE 44 CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY DEVELOPMENTAL SHARE, 2010–2014 100
FIGURE 45 GROWTH STRATEGIES SHARE, BY COMPANY, 2010–2014 101
FIGURE 46 REGIONAL REVENUE MIX OF TOP 5 MARKET PLAYERS 106
FIGURE 47 MERCK KGAA: BUSINESS OVERVIEW 107
FIGURE 48 MERCK KGAA: SWOT ANALYSIS 109
FIGURE 49 TOSOH CORPORATION: BUSINESS OVERVIEW 110
FIGURE 50 TOSOH CORPORATION: SWOT ANALYSIS 111
FIGURE 51 GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW 112
FIGURE 52 GENERAL ELECTRIC COMPANY: SWOT ANALYSIS 114
FIGURE 53 PALL CORPORATION: BUSINESS OVERVIEW 115
FIGURE 54 PALL CORPORATION: SWOT ANALYSIS 117
FIGURE 55 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 118
FIGURE 56 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS 120
FIGURE 57 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 121
FIGURE 58 PUROLITE CORPORATION: BUSINESS OVERVIEW 123
FIGURE 59 SEPRAGEN CORPORATION: BUSINESS OVERVIEW 125
FIGURE 60 KNAUER WISSENSCHAFTLICHE GERÄTE GMBH: BUSINESS OVERVIEW 126
FIGURE 61 KANEKA CORPORATION: BUSINESS OVERVIEW 127
FIGURE 62 GENSCRIPT USA INC.: BUSINESS OVERVIEW 129


【レポートのキーワード】

創薬、クロマトグラフィー樹脂、イオン交換クロマトグラフィー樹脂、親和クロマトグラフィー樹脂、疎水性相互作用クロマトグラフィー、サイズ排除クロマトグラフィー、マルチモードクロマトグラフィー、クロマトグラフィー技術

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[創薬におけるクロマトグラフィー樹脂の世界市場:イオン交換クロマトグラフィー、親和クロマトグラフィー、疎水性相互作用クロマトグラフィー等]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。H&I文字はH&Iグローバルリサーチ株式会社の商標(登録第5783645号)です。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。
※当サイトでは2016年05月31日現在 190,554 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆